The effect of antipyretic medications on mortality in critically ill patients with infection: A systematic review and meta-analysis

Critical Care and Resuscitation

Volumn 13, Issue 2, 2011, Pages 125-131

  Jefferies, Sarah ^a,b   Weatherall, Mark ^b,c   Young, Paul ^b   Eyers, Sally ^a,b,c   Perrin, Kyle G ^a,b   Beasley, C Richard W ^a,b  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^c UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT;

ANIMAL; CRITICAL ILLNESS; FEVER; HEALTH; HUMAN; INFECTION; META ANALYSIS; MORTALITY; REVIEW; SURVIVAL RATE;

ANIMALS; ANTIPYRETICS; CRITICAL ILLNESS; FEVER; HUMANS; INFECTION; SURVIVAL RATE; WORLD HEALTH;

EID: 79960609687     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Funk DJ, Parrillo JE, Kumar A. Sepsis and septic shock: a history. Crit Care Clin 2009; 25: 83-101, viii.
2. Arons MM, Wheeler AP, Bernard GR, et al. Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Crit Care Med 1999; 27: 699-707.
3. Kluger MJ, Kozak W, Conn CA, et al. The adaptive value of fever. Infect Dis Clin North Am 1996; 10: 1-20.
4. Oxford JS, Corcoran T, Schild GC. Naturally occurring temperaturesensitive influenza A viruses of the H1N1 and H3N2 subtypes. J Gen Virol 1980; 48: 383-9.
5. Enders JF, Shaffer MF. Studies on natural immunity to pneumococcus type III. J Exp Med 1936; 64: 7-18.
6. Kiang JG, Tsokos GC. Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther 1998; 80: 183-201.
7. Roberts NJ, Jr. Impact of temperature elevation on immunologic defences. Rev Infect Dis 1991; 13: 462-72.
8. Mackowiak PA, Marling-Cason M, Cohen RL. Effects of temperature on antimicrobial susceptibility of bacteria. J Infect Dis 1982; 145: 550-3.
9. Kurosawa S, Kobune F, Okuyama K, Sugiura A. Effects of antipyretics in rinderpest virus infection in rabbits. J Infect Dis 1987; 155: 991-7.
10. Vaughn LK, Veale WL, Cooper KE. Antipyresis: its effect on mortality rate of bacterially infected rabbits. Brain Res Bull 1980; 5: 69-73.
11. van der Zee CE, van Dam RH, Dwinger RH, et al. Flurbiprofen and immunosuppression of Trypanosoma brucei infection in the goat. Vet Immunol Immunopathol 1985; 8: 341-50.
12. Bryant RE, Hood AF, Hood CE, Koenig MG. Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med 1971; 127: 120-8.
13. Weinstein MP, Iannini PB, Stratton CW, Eickhoff TC. Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med 1978; 64: 592-8.
14. Doran TF, De Angelis C, Baumgardner RA, Mellits ED. Acetaminophen: more harm than good for chickenpox? J Pediatr 1989; 114: 1045-8.
15. Brandts CH, Ndjave M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997; 350: 704-9.
16. Graham NM, Burrell CJ, Douglas RM, et al. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis 1990; 162: 1277-82.
17. Stanley ED, Jackson, GG, Panusarn, C, et al. Increased viral shedding with aspirin treatment of rhinovirus infection. JAMA 1975; 231: 1248-51.
18. Prymula R, Siegrist CA, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009; 374: 1339-50.
19. Schulman CI, Namias N, Doherty J, et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect (Larchmt) 2005; 6: 369-75.
20. Diringer MN, Reaven NL, Funk SE, Uman GC. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med 2004; 32: 1489-95.
21. Manthous CA, Hall JB, Olson D, et al. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med 1995; 151: 10-4.
22. Villar J, Slutsky AS. Effects of induced hypothermia in patients with septic adult respiratory distress syndrome. Resuscitation 1993; 26: 183-92.
23. Nolan JP, Morley PT, Vanden Hoek TL, et al. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation 2003; 108: 118-21.
24. den Hertog H, van der Worp H, van Gemert H, et al. The paracetamol (acetominophen) in stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol 2009; 8: 434-40.
25. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34: 17-60.
26. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
27. Whitehead A. Meta-analysis of controlled clinical trials. Chichester, UK: Wiley & Sons, 2002.
28. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002; 21: 1539-58.
29. Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med 2001; 20: 641-54.
30. Bernard G, Wheeler A, Russell J, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997; 336: 912-9.
31. Bernard GR, Reines HD, Halushka PV, et al. Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. Am Rev Respir Dis 1991; 144: 1095-101.
32. Haupt MT, Jastremski MS, Clemmer TP, et al. The Ibuprofen Study G. Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. Crit Care Med 1991; 19: 1339-47.
33. Memis D, Karamanlioglu B, Turan A, et al. Effects of lornoxicam on the physiology of severe sepsis. Crit Care 2004; 8: R474-82.
34. Morris PE, Promes JT, Guntupalli KK, et al. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care 2010; 14: R125.
35. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
36. Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med 1992; 20: 724-6.